Chemo Drug Exposure Linked to CAR T-Cell Therapy Outcomes

Published Date: 22 Aug 2026

Optimal fludarabine exposure during lymphodepletion is associated with improved progression-free survival after CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do Anatomy Atlases Reflect Social Inequalities?

2.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

3.

Mammography with AI support is a secure method for detecting breast cancer.

4.

QOL Maintained With Giredestrant Combo in Advanced BC

5.

Talc Powder Not Linked to Lung Cancer in Women


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot